View in EDS

Noninferior Immunogenicity and Consistent Safety of Respiratory Syncytial Virus Prefusion F Protein Vaccine in Adults 50–59 Years Compared to ≥60 Years of Age.

Saved in:
Bibliographic Details
Title: Noninferior Immunogenicity and Consistent Safety of Respiratory Syncytial Virus Prefusion F Protein Vaccine in Adults 50–59 Years Compared to ≥60 Years of Age.
Authors: Ferguson, Murdo1, Schwarz, Tino F2, Núñez, Sebastián A3, Rodríguez-García, Juan4, Mital, Marek5, Zala, Carlos6, Schmitt, Bernhard7, Toursarkissian, Nicole8, Mazarro, Dolores Ochoa9, Großkopf, Josef10, Voors-Pette, Christine11, Mehta, Hemalini12, Hailemariam, Hiwot Amare13, Heusch, Magali de13, Salaun, Bruno13, Damaso, Silvia13, David, Marie-Pierre13, Descamps, Dominique13, Hill, Judith13, Vandermeulen, Corinne13 corinne.x.vandermeulen@gsk.com
Source: Clinical Infectious Diseases. 10/15/2024, Vol. 79 Issue 4, p1074-1084. 11p.
Database: Environment Complete
Description
ISSN:10584838
DOI:10.1093/cid/ciae364